Mehrwertsteuer auf Arzneimittel absenken - Anhebung der Zusatzbeiträge für gesetzlich Krankenversicherte verhindern

This procedure concerns a proposal to reduce the Value Added Tax (VAT) on medicines. The aim is to prevent a rise in supplementary health insurance contributions for those covered by statutory health insurance. This measure would directly affect individuals with statutory health insurance by aiming to keep their contributions stable. It also impacts the pharmaceutical sector and public finances through tax revenue adjustments.